Related Experiment Video

Updated: Sep 27, 2026

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

SHP2 regulates IL-2 induced MAPK activation, but not Stat3 or Stat5 tyrosine phosphorylation, in cutaneous T cell

Johannes Lundin Brockdorff1, Anders Woetmann, Tomas Mustelin

  • 1Institute of Medical Microbiology and Immunology, University of Copenhagen, Blegdamsvej 3c, 2200 Copenhagen-N, Denmark.

Cytokine
|January 25, 2003
PubMed

Insights

The phosphotyrosine phosphatase SHP2 positively regulates IL-2 induced MAPK activation in malignant T cells. SHP2 does not appear to affect Stat3 or Stat5 activation in cutaneous T cell lymphoma (CTCL) cells.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • The phosphotyrosine phosphatase SHP2 is implicated in regulating cell signaling pathways.
  • SHP2's role in interleukin-2 (IL-2) signaling, particularly in T cells, requires further elucidation.
  • Cutaneous T cell lymphoma (CTCL) is a type of T cell malignancy where IL-2 signaling may play a role.

Purpose of the Study:

  • To investigate the role of SHP2 in IL-2 induced activation of MAPK and Stat proteins.
  • To determine if SHP2 regulates IL-2 signaling in the context of malignant T cells (CTCL).

Main Methods:

  • Stable transfection of a human CTCL cell line (MyLa2059) with wild-type or inactive SHP2.
  • Stimulation of transfected cells with IL-2.
  • Assessment of MAPK, Stat3, and Stat5 activation and DNA binding.

Main Results:

  • Cells expressing inactive SHP2 exhibited reduced MAPK activation following IL-2 stimulation.
  • SHP2 activity positively correlates with IL-2 induced MAPK activation in CTCL cells.
  • Constitutive Stat3 phosphorylation and IL-2 induced Stat5 phosphorylation/DNA binding were not affected by SHP2 manipulation.

Conclusions:

  • SHP2 positively regulates IL-2 induced MAPK activation in malignant T cells.
  • SHP2 does not appear to be involved in the activation of Stat3 or Stat5 in CTCL cells.

More Related Videos

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes09:40

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes

Published on: September 28, 2018

Development and Application of Rapamycin-regulated Tyrosine Phosphatases06:56

Development and Application of Rapamycin-regulated Tyrosine Phosphatases

Published on: September 6, 2024

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...